MDxHealth Inc. - MDXH Net earnings per share for the last four quarters

Public company logo of MDxHealth, Inc. (MDXH)

MDxHealth SA (MDXH) specializes in developing molecular tests for prostate cancer detection. This chart of the market valuation demonstrates EPS dynamics, where the current value is 16.40, accounting for the partial outsourcing of IT infrastructure and logistics to third-party contractors. The high value of diagnostics enables the implementation of premium pricing power. However, marketing expenses and uncertainty regarding Medicare reimbursements are slowing the business's path to stable net profit.

MDXH MDxHealth: Earnings per share for the last twelve months in the range 02/11/2024 - 11/15/2026

Financial and market metric breakdowns for MDxHealth (MDXH)

- market price and analyst price targets:
Fundamental company valuation:MDxHealth MDXH
Finished products of mdxhealth.com

This indicator measures the rolling year earnings per share (EPS) trend, allowing for an assessment of business capitalization rates between quarterly reports. A positive trend confirms the efficiency of the operating model, while sharp peaks may signal an impending correction. By analyzing the relative EPS YoY growth over the last 12 months, an investor evaluates the fundamental stability of MDxHealth SA (MDXH). The stability of this metric is supported by the integration of precise urological tests into US insurance systems.

Competitor analysis for MDxHealth SA

A - Net earnings per share (EPS TTM)|Quest Corp (DGX) - Earnings per share for the last twelve months|ILMN - Net earnings per share for the last four quarters|Earnings per share for the last twelve months exactsciences.com|revvity.com (RVTY) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) BIO|Net earnings per share (EPS TTM) Anbio Biotechnology Ltd (NNNN)|Sotera Health - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) QuidelOrtho Corp QDEL|OPK - Earnings per share for the last twelve months|Earnings per share for the trailing year CDNA (caredx.com)|MRVI: Net earnings per share (EPS TTM)|Net earnings per share for the trailing year Fulgent Genetics FLGT|LAB (Standard BioTools Inc) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Cytek Biosciences, Inc.|Earnings per share for the last twelve months OraSure Technologies (OSUR)|XGN (Exagen) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) LUCD (Lucid Diagnostics Inc)|PRE - Net earnings per share for the last 12 months|IMDX: Net earnings per share for the last 12 months|Earnings per share for the trailing year TRIB (trinitybiotech.com)|PRPH (ProPhase Labs, Inc.) - Net earnings per share for the last 12 months|Net earnings per share for the last 12 months Ainos|Earnings per share for the last twelve months Co-Diagnostics Inc|HSCS (Heart Test Laboratories Inc.) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) BMRA|Cardio Diagnostics Holdings Inc. (CDIO) - Net earnings per share for the trailing year|Earnings per share for the last twelve months Onconetix ONCO|viraxbiolabs.com - Earnings per share for the last twelve months|BJDX - Earnings per share for the last twelve months|Earnings per share for the trailing year AWH (Aspira Women's Health Inc.)|AXDX: Net earnings per share (EPS TTM)|CNTG - Net earnings per share for the last four quarters|ENZ (enzo.com) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months FRES|Earnings per share for the last twelve months Genetic Technologies (GENE)|Net earnings per share for the last four quarters 23andMe Holding Co|Net earnings per share (EPS TTM) PMD (Psychemedics)